The EU Commission's interpretation of the Biocidal Regulations can allow SoftOx to enter the market with all its disinfectant products in the EU and EEA area

SoftOx Solutions AS (SoftOx) has previously been refused on a request for a
transitional arrangement from the Norwegian Environment Agency for its hand
disinfection products. In this context, the company has requested an assessment
and a clarifying statement from the European Commission.

Will be able to deliver on the National Hospital Tender (HINAS) and European
markets
The company's interpretation of the Biocidal Regulations is in line with the
Commission's statement regarding the possible transitional arrangements for the
company's hand and surface disinfectants.

"This is very good news for SoftOx. In our opinion the European Commission's
assessment will enable us to make our products available on the market and we
will be able to fulfil our obligations in accordance with the HINAS agreement.
The European Commission's analysis and assessment means that SoftOx can, if the
company wants to, go to all European markets with its disinfectant products for
hand and surface", says CEO Geir Almås.

"We are ready to meet increased demand"
The company have a pending application in process in the Norwegian Environment
Agency for approval of the company's hand and surface disinfection products. The
transitional arrangement described by the EU Commission gives the company the
opportunity to have the hand and surface products on the market until final
approval of the pending application is available.

"This is a scenario we have prepared for by buying 50 percent of Ose Water. We
are ready to meet potential increased demand from major European markets",
according to Almås.

For further information, please contact: 
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine M. Rød of SoftOx Solutions AS
Mail: [e-mail] 
Mobile: [phone] 

The information included in this announcement is defined as inside information
pursuant to MAR article 7, and is publicly disclosed in accordance with MAR
article 17. The announcement is made by the contact person.
 
About SoftOx Solutions AS 
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian 
BioTech company based in Oslo with the aim of helping to combat major threats to

human health, namely the emergence of antimicrobial resistance (AMR), biofilm 
infections in chronic wounds and the spread of viruses. For more information on 
SoftOx, visit www.soft-ox.com.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange